1Slovak ML,Kopeeky K J,Cassileth PA,et al.Karyotypic analysis predicts outcome of preremission and postremissiou therapy in adult acute myeloid leukemia:a Southwest Oneology Group/Eastern Cooperative Oncolagy Group Study.Blood,2000,96:4075-4083.
2Grimwade D,Walker H,Oliver F,et al.The importance of diagnostic cytogenetics on outcome in AML:analysis of 1,612 patients entered into the MRC AML 10 trial.Blood,1998,92:2322-2333.
4Shoenfeld Y,Rothenberg M,Berliner S,et al.Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukaemia at time of diagnosis.Seand J Haematol,1982,28:335-340.
6Sanz MA,Tallman MS,Lo-Coeo F.Practice points,consensus,and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia.Oncologist,2005,10:806-814.
7Raanani P,Shpilberg O,Ben-Bassat I,et al.Extramedullary disease and targeted therapies for hematological malignancies-is the association real? Ann Oneo1,2007,18:7-12.
8Pui CH.Toward optimal central nervous system-direetad treatment in ahildhood acute lymphoblastic leukemia.J Clin Oncol,2003,21:179-181.
9Burger B,Zimmermann M,Mann G,et al.Diagnostic eerebrospinal fluid examination in children with aoute lymphahlastie leukemia:signifieanee of low leukocyte counts with blasts or traumatic lumbar puncture.J Clin Oncol,2003,21:184-188.
6Gajjar A, Harrison PL, Standlund JT, et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia [J ]. Blood, 2000,96(10) :3381-3384.
7Pui CH. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia [J]. J Clin Oncol,2003,21 (2) : 179-181.
8Pui CH, Boyett JM, Rivera of total therapy studies 11, GK, et al. Long-term results 12 and 13A for childhood acute leukemia at St Jude Children Research Hospital [J] Leukemia, 2000,14 (12) : 2286-2294.
9Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukemia [J]. Lancet Oneol,2008,9(3):257-268.
10Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications [ J ]. Semin Oncol, 2009,36 (Suppl 2) : S2-S16.
